As shown in eFigure 1A in the Supplement, plasma from the patients inhibited SARS-CoV-2pseudovirus infection of 293T/ACE2 cells in a concentration-dependent manner. The gene discussed is ACE2; the disease is severe acute respiratory syndrome.